CAS: 7449-74-3; N-Methyl-N-(Trimethylsilyl)Acetamide

该化合物是一种属于氨化物类的有机化合物,其特征为:一个甲基组和一个附于氮原子的三甲基硅基组,这提高了氮原子的溶性性和再活动性,该组通常没有色,可变成黄色的黄色液体,因其在分析化学中,特别是在气相色谱学中能够发挥衍生剂的作用而闻名;其结构允许反应性中间体稳定,使其在各种合成应用中有用;N-Me乙-N(三甲基硅)乙酰胺也具有相对低的挥发性和中度极性,有助于其与极性组形成稳定的衍生物;此外,该组物通常被用于制成酒精,氨和致虫酸的硅化衍生物,便利其分析和定性;在处理该化合物时,应注意安全防范措施,因为如果吸入或沉入,可能会对健康造成危害.

结构式图片

相似化合物

24589-78-4 13435-12-6 996-50-9

欧盟法规

REACH注册ECHA物质C&L通报REACH预注册

合成工艺路线路线简述

    N-Methyl-Trimethylsilylacetamid 180.0~200.0 °C,1.07 Kpa 条件下,反应生成 N-甲基-N-(三甲基硅基)乙酰胺
    参考文献:烯酮与甲硅烷基化胺或酰胺的相互作用
    标题:烯酮与甲硅烷基化胺或酰胺的相互作用
    摘要:在对乙烯酮与单或二烷基氨基硅烷的相互作用的研究中,观测到许多新的重排.当受到烯酮作用时,二烷基氨基硅烷根据所施加的条件,会反应生成β-甲硅烷氧基乙烯基乙酸(i)的酰胺(路线" A",方案a)或甲硅烷基乙酸的酰胺(II)(路线" B"," C").在两种情况下,均分离出中间体α-甲硅烷氧基乙烯基二烷基胺(iii),可以将其重新排列以得到酰胺(II).
    DOI:10.1016/s0022-328X(00)88613-1

    海关参考信息

    专利信息


    专利号:US-2022298204-A1
    优先权日:2019-07-05
    标题 :Synthesis of a-amanitin and its derivatives
    发明人:SIEGERT MARY-ANN; KNITTEL CAROLINE HERTA; SÜSSMUTH RODERICH
    权利人:PURE BIOORGANICS SIA
    摘要:The present invention relates to the chemical synthesis of α-amanitin and its derivatives. The present invention also relates to intermediate products of the α-amanitin synthesis.

    专利号:EP-3792250-A1
    优先权日:2019-09-13
    标题:Synthesis of alpha-amanitin and its derivatives
    发明人:SIEGERT MARY-ANN; KNITTEL CAROLINE HERTA; SÜSSMUTH RODERICH
    权利人:PURE BIOORGANICS SIA
    摘要:The present invention relates to the chemical synthesis of α-amanitin and its derivatives. The present invention also relates to intermediate products of the α-amanitin synthesis.

    专利号:WO-9741093-A1
    优先权日:1996-04-30
    标 题:Methods for the synthesis of fmoc protected amines
    发明人:BAER TED ALLEN; RAILLARD STEPHEN PETER
    权利人:AFFYMAX TECH NV; BAER TED ALLEN; RAILLARD STEPHEN PETER
    摘要:Methods for the synthesis of Fmoc-protected amines are provided. These methods involve the treatment of an amine component with a silylating agent and then an activated Fmoc-reagent. The methods can be conducted under anhydrous conditions.

    专利号:US-9605019-B2
    优先权日:2011-07-19
    标 题:Methods for the synthesis of functionalized nucleic acids
    发明人:VERDINE GREGORY L; MEENA; IWAMOTO NAOKI; BUTLER DAVID CHARLES DONNELL
    权利人:VERDINE GREGORY L; MEENA; IWAMOTO NAOKI; BUTLER DAVID CHARLES DONNELL; WAVE LIFE SCIENCES LTD
    摘要:The present application, among other things, provides technologies, e.g., reagents, methods, etc. for preparing oligonucleotides comprising phosphorothiotriesters linkages, e.g., oligonucleotides having the structure of IIIa, IIIb or IIIc. In some embodiments, provided methods comprise reacting an H-phosphonate of structure Ia or Ib with a silylating reagent to provide a silyloxyphosphonate, and reacting the silyloxyphosphonate with a thiosulfonate reagent of structure IIa or IIb to provide an oligonucleotide of structure IIIa or IIIb. In some embodiments, provided methods comprise reacting an H-phosphonate of structure Ic with a silylating reagent to provide a silyloxyphosphonate, reacting the silyloxyphosphonate with a bis(thiosulfonate) reagent of structure IVc to provide a phosphorothiotriester comprising a thiosulfonate group of structure Vc, and then reacting the phosphorothiotriester comprising a thiosulfonate group of structure Vc with a nucleophile of structure VIc to provide an oligonucleotide of structure IIIc.

    专利号:EP-0135088-B1
    优先权日:1983-08-13
    标 题 :7-Amino-3[1-pyridiniomethyl]-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-en-2-carboxylates, process for their preparation and their use as intermediates in the synthesis of beta-lactam antibiotics
    摘要:1. Compounds of the general formula (1) see diagramm : EP0135088,P12,F1 in which R represents hydrogen or methoxy, and X and Y, independently of one another, represent the following meanings : hydrogen ; halogen ; cyano ; hydroxyl ; C1 -C4 -alkoxy ; phenoxy ; amino, C1 -C4 -alkylamino, C1 -C4 -dialkylamino or C1 -C4 -alkanoylamino ; carboxyl ; C1 -C4 -alkanoyl ; benzoyl ; phenyl-C1 -C4 -alkanoyl ; C1 -C4 -alkoxycarbonyl ; sulphamoyl ; carbamoyl ; N-C1 -C4 -alkyl-, N,N-C1 -C4 -dialkyl- or N-C1 -C4 -alkoxycarbonylcarbamoyl ; allophanoyl and 4-C1 -C4 -alkylallophanoyl ; C1 -C4 -alkylsulphonyl ; C1 -C4 -alkylthio ; C1 -C6 -alkyl or alkenyl, C3 -C7 -cycloalkyl or cycloalkenyl, phenyl, heterocyclyl having 5- to 6-membered rings and 1 to 4 heteroatoms from the group comprising O, N and/or S, phenylalkyl or heterocyclylalkyl in the above mentioned meaning with 1 to 2 C atoms in the alkyl moiety, each of which is optionally substituted one or more times by hydroxyl, C1 -C4 -alkoxy, halogen, cyano, carboxyl and C1 -C4 -alkoxycarbonyl, C1 -C4 -alkanoyl, C1 -C4 -alkylsulphonyl or -sulphinyl, amino, or mono- or di-C1 -C4 -alkylamino, or C1 -C4 -alkoxyimino, excepting the radicals hydrogen-hydrogen, amino/hydrogen and carbamoyl/hydrogen ; or X and Y together represent a carbocyclic radical which is fused to the pyridine ring in 2.3 or 4.5 position and has 5 - 7 carbon atoms which are optionally replaced by O, S or N heteroatoms.

    专利号:WO-2024146948-A1
    优先权日:2023-01-05
    标题:Peptide synthesis method involving sterically hindered tri-tert-butyl-tryptophan (tbt) residue
    发明人:EKSTEEN JACOBUS JOHANNES; SVENDSEN JOHN SIGURD; MALMEDY FLORENCE; GUEVARA JONATHAN
    权利人:AMICOAT AS
    摘要:The invention is directed to a method of peptide synthesis comprising reacting a compound of Formula (I) or a salt thereof with a carbodiimide reagent to form an O-acylisourea intermediate; reacting the O-acylisourea intermediate with an additive to form an activated ester; and reacting the activated ester with an amino-containing moiety which is an amino acid, a peptide or a salt thereof comprising an amino group, wherein the amino group forms an amide bond with the carbonyl marked * in Formula (I); wherein the compound of Formula (I) has the structure: and wherein R1 and R2 are as defined in the disclosure. The invention is also directed to a compound of Formula (III) as defined in the disclosure or a salt thereof.
    海门瑞一医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: https://cn.ruiyitech.com/
    电话:021-54718086👤
    📞 海门瑞一医药科技有限公司⚠️参考联系方式

    电话: 021-54718086
    邮件:sales@ruiyitech.com
    网址: https://cn.ruiyitech.com/
    地址:江苏海门大庆路19号
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    江苏海门大庆路19号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别. 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    [参考文献]: Akiko Maehara, Et Al. Comparison Of Stent Expansion Guided By Optical Coherence Tomography Versus Intravascular Ultrasound: The Ilumien Ii Study (Observational Study Of Optical Coherence Tomography [参考文献]: Constanza E Fernández, Et Al. Effect Of The Probiotic Lactobacillus Rhamnosus Lb21 On The Cariogenicity Of Streptococcus Mutans Ua159 In A Dual-Species Biofilm Model. Caries Res. 2015;49(6):583-90.
    [参考文献]: Hannah L F Cooper, Et Al. Racialized Risk Environments In A Large Sample Of People Who Inject Drugs In The United States. Int J Drug Policy. 2016 Jan:27:43-55.
    [参考文献]: Hong Zhai, Et Al. Development Of Dual-Emission Ratiometric Probe-Based On Fluorescent Silica Nanoparticle And Cdte Quantum Dots For Determination Of Glucose In Beverages And Human Body Fluids. Food Chem. 2016 Aug 1:204:444-452.
    [参考文献]: Ming Yan, Et Al. Cytotoxicity Of Cdte Quantum Dots In Human Umbilical Vein Endothelial Cells: The Involvement Of Cellular Uptake And Induction Of Pro-Apoptotic Endoplasmic Reticulum Stress. Int J Nanomedicine. 2016 Feb 2:11:529-42.

    合成参考文献


    摘要:Spivey, A. C.; Diaper, C. M., Science of Synthesis, (2003) 5, 134.
    摘要:Bailey, T. R., Science of Synthesis, (2005) 21, 815.
    摘要:Bailey, T. R., Science of Synthesis, (2005) 21, 813.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知